Ina ia foia faʻafitauli e fesoʻotaʻi ma le COVID-19, e taua le suʻesuʻeina o le maʻi i le amataga o faʻamaʻi. E tusa ai ma le Faalapotopotoga o le Soifua Maloloina a le Lalolagi (WHO), e sili atu i le 180 miliona mataupu lelei o le COVID-19 na maua seʻia oʻo ia Iuni 2021. Ole fua o faʻamaʻi lelei e mafai ona faʻatonutonuina ile vave suʻesuʻeina ma togafitiga.

SARS-CoV-2 antigen rapid test kits o le ituaiga sili ona taatele o suʻega na faʻatatau i le tau USD 2,903.0 Mn i le 2020. E talia lautele ona o le faigofie, faigofie ma le vave natura i le faʻasologa o suʻesuʻega.

O loʻo faʻateleina le manaʻoga mo suʻega o le tausiga ona o tulaga lelei e pei o le maualalo o taimi manaʻomia, auaunaga ile fale, ma le tau aoga. O mea nei o le a faʻamalosia ai le manaʻoga mo suʻega o le tausiga ile taimi ole vaʻaiga. Mo se faʻataʻitaʻiga, i le aso 28 Iulai 2020, na faʻasalalau ai e Roche le faʻalauiloaina o le SARS-CoV-2 Rapid Antibody Test i le galulue faʻatasi ma SD Biosensor Inc.

Faatasi ai ma le faʻalauiloaina o tui ma le atinaʻeina o le tele o tui puipui e malo, o le numera o COVID-19 o loʻo faʻamoemoe e paʻu i le faʻaiʻuga o le 2021, peitaʻi, o loʻo faʻamoemoe o le a faʻaauau pea suʻega tusa lava pe o le loka i le tele o atunuu o le a aveese. O lo'o taula'i tagata ta'a'alo autu i le fa'amalosia o a latou fa'atasiga ma fa'atauga fa'atasi ai ma mea fou na maua o tekonolosi.

Ina ia tumau i luma o au tauva, talosaga mo se faʻataʻitaʻiga - https://www.futuremarketinsights.com/reports/sample/rep-gb-13636

Mea'ai Aveese mai le COVID-19 Au'aunaga Su'ega Su'esu'ega Maketi

SARS-CoV-2 antigen rapid test kits e fa'amoemoe e sili atu i le 67% le su'ega a Amerika COVID-19 maketi i le 2031, ona o le maualuga o le aoga i su'esu'ega.
O falema'i falema'i na sili atu nai lo le 32% o le maketi i le 2021. O le fa'atuputeleina o tagata mama'i mo togafitiga ma tausiga tigaina na fa'atupuina ai le tuputupu a'e.
O Kanata o le a atagia mai ai le tuputupu aʻe tumau ma le 4.8% CAGR, faʻamalosia e le matua, faʻatupeina e le malo faʻalesoifua maloloina.
O le US o le a atagia vave le tuputupu aʻe i le CAGR e tusa ma le 5.7% e oʻo atu i le 2021-2031. US o loʻo taʻimua ona o le maualuga o tupe faʻaalu mo le soifua maloloina, ma le iai o taʻaloga taʻutaʻua.
Pasila o le atunuʻu taʻutaʻua i Latina Amerika, faʻatatau e tusa ma le 54% o le vaega faʻaitulagi i le 2021, lagolagoina e le faigofie ona maua i tekinolosi manaʻomia.

“O le suiga o le taulaʻi mai le suʻega i le tui e faʻamoemoe e faʻalavelaveina le tuputupu aʻe o maketi i se taimi lata mai. Ae ui i lea, o le taulaʻi i suʻega mo femalagaaiga faavaomalo, suʻesuʻega faifaipea a le aufaigaluega fomaʻi ma suʻega mo tagata mamaʻi e maua i faʻailoga pei o le flu e faʻamoemoe e faʻaauau pea ona fesoasoani i le tuputupu aʻe o maketi, " fai mai le Future Market Insight suʻesuʻe.

Mana'omia nisi fa'amatalaga?

Future Market Insights o loʻo aumaia ai le lipoti o suʻesuʻega atoatoa i luga o le faʻatupulaia o tupe maua i le lalolagi, faʻaitulagi, ma le atunuʻu ma tuʻuina atu se auʻiliʻiliga o faiga faʻapisinisi lata mai i vaega taʻitasi mai le 2016 i le 2031. au'ili'ili e fa'atatau i itu uma o le maketi ma tu'uina atu se fa'ata'ita'iga atoa o maketi i le tagata faitau. O le suʻesuʻega e maua ai faʻamatalaga faʻamalosi i luga ole maketi ole suʻega ole suʻega ole COVID-19 ile faʻavaeina ole ituaiga suʻega ile auiliiliga, e aofia ai itu uma ole maketi e pei ole Suʻega ituaiga, ituaiga faʻataʻitaʻiga, alalaupapa tufatufaina i Amerika i Matu ma Amerika Latina itulagi.

Amerika COVID-19 su'ega Maketi i vaegaItuaiga Su'ega:

SARS-CoV-2 IgM/IgG Antibody Rapid Test Kits
SARS-CoV-2 Antigen Rapid Test Kits
Tele Su'ega RT-PCR Taimi Moni Pusa

Maua se Lipoti Faʻatulagaina e Faʻafetaui i ou manaʻoga, Fesili mai le Suʻesuʻega Maketi Faʻapitoa - https://www.futuremarketinsights.com/ask-question/rep-gb-13636

Ituaiga faataitaiga:

Toto
Nasopharyngeal Swabs

Fa'asoa Fa'asoa:

Falemai Falemaʻi
Su'esu'ega Su'esu'e
Fale Talavai Laiti
Fale Faʻafomai
Alatele Fa'atauga i luga ole laiga

Itumalo:

Amerika i matu
Amerika Latina

Faʻamatalaga punaoa

OA MEA E AVEA MAI LENEI TUSI:

The study provides compelling insights on the COVID-19 testing treatment market on basis of the test type in detail, cover every aspect of the market such as Test type, sample type, distribution channel across North America and Latin America region.
With the launch of vaccines and development of mass vaccination programs by governments, the number of COVID-19 cases is expected to drop by the end of 2021, however, it is expected that testing will continue even as lockdown in many countries will be lifted.
The global COVID-19 testing market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.